Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 11Fallopian Tube Neoplasms 8Sarcoma 3Sarcoma, Ewing 2Neoplasms 2Neoplasm Metastasis 2Multi-centric Castleman's Disease 2Breast Neoplasms 2Sarcoma, Synovial 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1Peritoneal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Cancer Recurrent 1Osteosarcoma 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphadenopathy 1Liposarcoma 1Leiomyosarcoma 1Hodgkin Disease 1Histiocytoma, Malignant Fibrous 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Mucinous Adenocarcinoma 1Dermatofibrosarcoma 1Acquired Immunodeficiency Syndrome 1

Interventions

X-Rays 6Cyclophosphamide 6Specimen Handling 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Nuclear Medicine Department, Hospital 4Biopsy 4fludarabine 3Gemcitabine 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2olaparib 2mifamurtide 2larotrectinib 2ivosidenib 2fludarabine phosphate 2ensartinib 2cabozantinib 2Methotrexate 2Mesna 2Ifosfamide 2Eflornithine 2Cisplatin 2trastuzumab deruxtecan 1tazemetostat 1talazoparib 1selinexor 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × liposomal doxorubicin × 30 days × Clear all
NCT05210374 2026-06-05

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Case Comprehensive Cancer Center

Phase 1 Recruiting
24 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡